HOME >> MEDICINE >> NEWS
Acellular pertussis vaccine proves effective in adults, adolescents

A vaccine to protect adults and adolescents against illness due to Bordetella pertussis infection--or whooping cough--has proved more than 90 percent effective in a national, large-scale clinical study, according to research results published in this week's issue of The New England Journal of Medicine. The vaccine, researchers say, could be used to stem the increase in pertussis cases among adults and adolescents in the United States and thereby prevent the prolonged cough illness, which can result in hospitalization, pneumonia and cracked ribs in those populations. An important additional benefit of the vaccine may be to decrease transmission of the B. pertussis bacterium to infants, who are particularly vulnerable to severe illness, complications and death resulting from whooping cough. The illness annually affects 50 million people worldwide.

"During the 1990s, the number of reported pertussis cases among adolescents and adults more than doubled in the United States as the protective effects of earlier childhood immunizations have waned," says Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, which funded the study. "This new study shows that an effective adult acellular pertussis vaccine is feasible and if routinely used could provide the U.S. population greater protection against the disease."

Known as the Adult Pertussis Trial, the 2.5-year study involved 2,781 healthy individuals between 15 and 65 years of age. Volunteers were randomly assigned to one of two similarly sized groups that received either the acellular pertussis vaccine or the control hepatitis A vaccine (Havrix). For purposes of the trial, pertussis cases were defined as illnesses with a cough lasting at least five days that occurred more than 28 days after vaccination and were confirmed through blood and nasal mucus testing.

Joel I. Ward, M.D., of the Center for Vaccine Research at the Un
'"/>

Contact: Kathy Stover
stoverk@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
12-Oct-2005


Page: 1 2

Related medicine news :

1. Booster vaccine for adolescents and adults that includes protection against pertussis shows promise
2. FDA approves Boostrix a new US vaccine for adolescents against pertussis
3. Traditional Chinese exercises may increase efficacy of flu vaccine
4. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
5. Study reveals gaps in vaccine financing for underinsured children
6. Trials underway for essential new TB vaccine
7. Hib vaccine: A critical ally in Asias effort to reduce child deaths
8. Progress toward an antitumor vaccine
9. Chemotherapy may enhance the effectiveness of brain tumor vaccines
10. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
11. International studies show high efficacy for HPV vaccine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/22/2020)... WEST ISLIP, N.Y. (PRWEB) , ... July 22, 2020 , ... ... – nobody wants them. “Some people may like a summer glow,” notes Angie Seelal, ... “but nobody likes the dark spots that show up years later and make us ...
(Date:7/22/2020)... ... July 22, 2020 , ... Healthcare ... its new Data Curation as a Service (DCaaS) solution for payers, providers, healthcare ... specific clinical data curation parameters and are custom tailored to provide clients a ...
(Date:7/18/2020)... ... , ... Nader Sanai, M.D., director of the Ivy Brain Tumor Center at ... Glioblastoma Awareness Day (#GBMDay) on July 22, 2020 to raise national consciousness. , ... , the most common and aggressive form of brain cancer. It also honors those ...
(Date:7/10/2020)... , ... July 10, 2020 , ... Inversion therapy is ... stretch out the spine and relieve back pain.” Ergo, the theory is that if ... relieved while implementing traction for the spine using the head and upper body as ...
(Date:7/10/2020)... ... July 09, 2020 , ... Ziegler, a specialty investment bank, is pleased ... Home d/b/a Beacon Hill at Eastgate (Beacon Hill). The Series 2020 Bank Bonds ... with a 3-year amortization that will be retired with initial entrance fees from the ...
Breaking Medicine News(10 mins):
(Date:7/31/2020)... ... July 31, 2020 , ... Psyma Group AG, a global ... data collection provider, recently released the results of an international survey on the ... France. , “COVID-19 continues to have a major disruptive impact on our daily ...
(Date:7/22/2020)... ... July 22, 2020 , ... Local animal nutrition expert, Dr. Anoosh ... their new pet food and supplies company – Pet Wants Lubbock. , Pet Wants’ ... enriched with vitamins and minerals for a complete and balanced diet in every bite. ...
(Date:7/10/2020)... ... 10, 2020 , ... Precision ADM, Inc. (“Precision ADM” or ... announced that their CANSWAB™ nasopharyngeal swabs are the first Canadian-made COVID-19 testing product ... swab design and has trademarked the name CANSWAB™ for distribution. The collection capability ...
Breaking Medicine Technology:
Cached News: